FLT3-ITD mutations are present in 10–20% of CBF leukemias [56], and some reports suggest a negative prognostic impact [55,64], possibly restricted to high allelic ratio (AR) cases [56], or when patients with inv(16) and trisomy 22 are excluded [64]. Here, CEBPZ is linked to leukemia.